More:    MJNA HOME        CANNABIS NEWS        SHOP        CONTACT 

  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
Medical Marijuana Inc.’s HempMedsPX Named Sponsor of High Times Medical Cannabis Cup in Seattle, Washington

Medical Marijuana Inc.’s HempMedsPX Named Sponsor of High Times Medical Cannabis Cup in Seattle, Washington

by adminAdrianRamirez | Aug 28, 2013 | Company News, HempMeds, Press Releases

HempMedsPX Will Exhibit Hemp-Based Cannabidiol (CBD) Products at Seattle US Cannabis Cup SAN DIEGO, Aug. 28, 2013 (GLOBE NEWSWIRE) — Medical Marijuana Inc. (OTC Pink:MJNA) is pleased to inform shareholders and the general public that HempMedsPX—a corporate...
CanChew® Biotechnologies Signs Exclusive Russia/CIS Distributorship

CanChew® Biotechnologies Signs Exclusive Russia/CIS Distributorship

by adminAdrianRamirez | Aug 22, 2013 | Company News, Press Releases

Annual $2 Million Wholesale Purchase of CanChew Required for Russia and the Commonwealth of Independent States   SAN DIEGO, Aug. 22, 2013 (GLOBE NEWSWIRE) — CanChew Biotechnologies, a joint venture company with Medical Marijuana Inc. (OTC Pink:MJNA), is...
Medical Marijuana Inc.’s Joint Venture Company, CanChew Biotechnologies, Signs Exclusive Russia/CIS Distributorship

Medical Marijuana Inc.’s Joint Venture Company, CanChew Biotechnologies, Signs Exclusive Russia/CIS Distributorship

by adminAdrianRamirez | Aug 22, 2013 | Company News, Press Releases

Annual $2 Million Wholesale Purchase of CanChew Required for Russia and the Commonwealth of Independent States SAN DIEGO, Aug. 22, 2013 (GLOBE NEWSWIRE) — CanChew Biotechnologies, a joint venture company with Medical Marijuana Inc. (OTC Pink:MJNA), is delighted...
Medical Marijuana Inc. Announces Second Quarter 2013 Shareholders Report

Medical Marijuana Inc. Announces Second Quarter 2013 Shareholders Report

by adminAdrianRamirez | Aug 13, 2013 | Company News, HempMeds, Press Releases, Wellness Managed Services

Company Earned $6 Million on $8.8 Million Gross Income; Adds Marketing and Sales Divisions; Moves Into New, Expanded Facility SAN DIEGO, Aug. 13, 2013 (GLOBE NEWSWIRE) — Medical Marijuana, Inc. (OTC:MJNA), a leading cannabis and hemp industry innovator, today...
CanChew Biotechnologies and Medical Marijuana Inc. Elects CEO, CMO and CTO

CanChew Biotechnologies and Medical Marijuana Inc. Elects CEO, CMO and CTO

by adminAdrianRamirez | Jul 30, 2013 | Canchew, Company News, Industry Updates, Press Releases

Medical Marijuana Inc. Holdings Announces Commencement of Clinical Trials for New Pharmaceutical Product San Diego, CA (eTeligis via ACCESSWIRE) 7/30/2013 – Medical Marijuana Inc. (OTC PINK: MJNA) and CanChew Biotechnologies are pleased to inform shareholders...
« Older Entries
Next Entries »

Recent Posts

  • Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
  • Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets
  • Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Participates in Research Finding Promising Therapeutic Benefits of CBD in Parkinson’s Disease Treatment

Recent Comments

No comments to show.

Home     Company    Education     Careers     Shop

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Food and Drug Administration (FDA) Disclosure

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.

© 2021 Medical Marijuana, Inc. All Rights Reserved.